Descending Thoracic Aortic Aneurysms: Is There a New Plan A?

The last available evidence suggests that open surgery should be the preferred treatment for intact descending thoracic aortic aneurysms. However, this study recently published in J Am Coll Cardiol, seems to have steered the wheel.

screening aneurisma aorta abdominalIn this study, open surgery was associated to increased early mortality and lower late mortality. Despite this long-term benefit, mean survival favored endovascular repair. This evidence suggests endovascular repair should be the first choice when it comes to intact thoracic aortic aneurysms.

 

This retrospective analysis used propensity score matching to compare 1235 patients undergoing surgery against 2470 patients undergoing endovascular repair between 1999 and 2010, followed up until 2014. The study looked into perioperative mortality and survival. Reinterventions were among the secondary end points.


Read also: Several Features Define a Hostile Neck in AAA patients, but Only One Makes the Difference.


Periprocedural mortality was higher for the surgery group, with differences between high volume (OR: 1.97, CI 95% 1.53 to 2.61) and low volume centers (OR: 3.62 CI 95% 2.88 to 4.51), though this reversed by the end of the study. Despite early and late survival rates, mean survival after the 9-year follow-up was better with endovascular repair (p<0.001). Reintervention risk (a secondary end point) favored surgery.

 

Conclusion

Conventional surgery is associated with higher early mortality and lower late mortality compared against endovascular repair. After a 9-year follow-up, survival favors endovascular repair, which is why this should be the preferred course of action.

 

Original title: Endovascular Versus Open Repair of Intact Descending Thoracic Aortic Aneurysms.

Reference: Peter Chiu et al. J Am Coll Cardiol 2019;73:643–51.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...